Showing results (91-100 of 207) with videos related to

Sort By:
Pageof 21
AIDS Research and Human Retroviruses|November 1, 1995
Low anticoagulant heparin retains anti-HIV type 1 activity in vitroD R Coombe, H A Harrop, J Watton, et al.
Thrombosis and Haemostasis|April 1, 1995
Measurement of activated factor IX in factor IX concentrates: correlation with in vivo thrombogenicityE Gray, J Tubbs, S Thomas, et al.
American Journal of Clinical Pathology|May 16, 1998
Minimum lyophilized plasma requirement for ISI calibration. European Concerted Action on AnticoagulationL Poller, T W Barrowcliffe, A M van den Besselaar, et al.
Thrombosis and Haemostasis|November 3, 1998
Modification of factor VIII in therapeutic concentrates after virus inactivation by solvent-detergent and pasteurisationS Raut, M Di Giambattista, S A Bevan, et al.
Thrombosis and Haemostasis|December 1, 1996
European Concerted Action on Anticoagulation (ECAA)-the multicentre calibration of rabbit and human ECAA reference thromboplastins. Steering CommitteeL Poller, T W Barrowcliffe, A M van den Besselaar, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1981
Factor VIII-related activities in therapeutic concentratesT W Barrowcliffe, G Kemball-Cook, G Morris, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentratesY Lin, X Yang, M-C Chevrier, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
A collaborative study to establish the 1st International Standard for factor XIII plasmaS Raut, R E Merton, P Rigsby, et al.
Pageof 21